| Mar 3, 2026 |
Mar 5, 2026 |
Brosius Mark
|
SVP & Chief Mfg and Supply Cha |
Sell |
8.8
|
-3,658
|
-55.73%
|
✓
|
$1.8M |
| Feb 27, 2026 |
Mar 3, 2026 |
Widman Fredrik
|
VP Corporate Controller |
Sell |
20.0
|
-600
|
-16.31%
|
✓
|
$299.2K |
| Mar 2, 2026 |
Mar 3, 2026 |
Curet Myriam
|
EVP & Chief Medical Officer |
Sell |
8.8
|
-4,853
|
-92.23%
|
✓
|
$2.4M |
| Feb 28, 2026 |
Mar 3, 2026 |
Jeddi Iman
|
SVP & GM da Vinci Platforms & |
Sell |
37.5
|
-4,466
|
-11.22%
|
✗
|
$2.2M |
| Feb 28, 2026 |
Mar 3, 2026 |
GUTHART GARY S
|
Director |
Sell |
36.3
|
-14,302
|
-1.09%
|
✗
|
$7.2M |
| Feb 28, 2026 |
Mar 2, 2026 |
Samath Jamie
|
CFO |
Sell |
37.5
|
-5,716
|
-18.43%
|
✗
|
$2.9M |
| Feb 28, 2026 |
Mar 2, 2026 |
LOEB GARY
|
EVP & Chief Legal and Complian |
Sell |
40.0
|
-1,562
|
-19.33%
|
✗
|
$786.5K |
| Feb 28, 2026 |
Mar 2, 2026 |
Charlton Henry L
|
EVP & Chief Commercial and Mkt |
Sell |
37.5
|
-5,135
|
-22.94%
|
✗
|
$2.6M |
| Feb 28, 2026 |
Mar 2, 2026 |
Rosa David J.
|
CEO |
Sell |
36.3
|
-12,357
|
-1.69%
|
✗
|
$6.2M |
| Feb 28, 2026 |
Mar 2, 2026 |
Brosius Mark
|
SVP & Chief Mfg and Supply Cha |
Sell |
37.5
|
-4,590
|
-34.01%
|
✗
|
$2.3M |
| Feb 27, 2026 |
Mar 2, 2026 |
Curet Myriam
|
EVP & Chief Medical Officer |
Sell |
8.8
|
-6,997
|
-52.00%
|
✓
|
$3.5M |
| Feb 26, 2026 |
Feb 27, 2026 |
WADORS PATRICIA L
|
SVP Chief Human Resources Offi |
Sell |
11.3
|
-458
|
-100.00%
|
✓
|
$230.4K |
| Feb 26, 2026 |
Feb 27, 2026 |
Jeddi Iman
|
SVP & GM da Vinci Platforms & |
Sell |
40.0
|
-972
|
-3.12%
|
✗
|
$492K |
| Feb 26, 2026 |
Feb 27, 2026 |
Charlton Henry L
|
EVP & Chief Commercial and Mkt |
Sell |
40.0
|
-1,224
|
-11.03%
|
✗
|
$619.6K |
| Feb 26, 2026 |
Feb 27, 2026 |
Samath Jamie
|
CFO |
Sell |
40.0
|
-1,638
|
-8.19%
|
✗
|
$829.1K |
| Feb 26, 2026 |
Feb 27, 2026 |
LOEB GARY
|
EVP & Chief Legal and Complian |
Sell |
40.0
|
-1,212
|
-11.41%
|
✗
|
$613.5K |
| Feb 26, 2026 |
Feb 27, 2026 |
Curet Myriam
|
EVP & Chief Medical Officer |
Sell |
37.5
|
-2,309
|
-32.94%
|
✗
|
$1.2M |
| Feb 26, 2026 |
Feb 27, 2026 |
Widman Fredrik
|
VP Corporate Controller |
Sell |
42.5
|
-491
|
-18.76%
|
✗
|
$248.5K |
| Feb 26, 2026 |
Feb 27, 2026 |
Rosa David J.
|
CEO |
Sell |
40.0
|
-3,027
|
-0.65%
|
✗
|
$1.5M |
| Feb 26, 2026 |
Feb 27, 2026 |
GUTHART GARY S
|
Director |
Sell |
42.5
|
-4,163
|
-0.32%
|
✗
|
$2.1M |
| Feb 26, 2026 |
Feb 27, 2026 |
Brosius Mark
|
SVP & Chief Mfg and Supply Cha |
Sell |
40.0
|
-1,288
|
-28.02%
|
✗
|
$651.9K |
| Feb 10, 2026 |
Feb 11, 2026 |
Curet Myriam
|
EVP & Chief Medical Officer |
Sell |
10.0
|
-943
|
-31.31%
|
✓
|
$465.8K |
| Feb 10, 2026 |
Feb 11, 2026 |
Widman Fredrik
|
VP Corporate Controller |
Sell |
11.3
|
-435
|
-39.73%
|
✓
|
$214.7K |
| Feb 10, 2026 |
Feb 10, 2026 |
Rosa David J.
|
CEO |
Sell |
45.0
|
-724
|
-0.31%
|
✗
|
$356.8K |
| Feb 10, 2026 |
Feb 10, 2026 |
GUTHART GARY S
|
Director |
Sell |
45.0
|
-1,306
|
-0.10%
|
✗
|
$643.6K |
| Feb 10, 2026 |
Feb 10, 2026 |
LOEB GARY
|
EVP & Chief Legal and Complian |
Sell |
42.5
|
-172
|
-4.44%
|
✗
|
$84.8K |
| Feb 10, 2026 |
Feb 10, 2026 |
Jeddi Iman
|
SVP & GM da Vinci Platforms & |
Sell |
42.5
|
-309
|
-1.12%
|
✗
|
$152.3K |
| Feb 10, 2026 |
Feb 10, 2026 |
Samath Jamie
|
CFO |
Sell |
42.5
|
-496
|
-5.98%
|
✗
|
$244.4K |
| Feb 10, 2026 |
Feb 10, 2026 |
Charlton Henry L
|
EVP & Chief Commercial and Mkt |
Sell |
42.5
|
-492
|
-11.75%
|
✗
|
$242.5K |
| Feb 10, 2026 |
Feb 10, 2026 |
Brosius Mark
|
SVP & Chief Mfg and Supply Cha |
Sell |
42.5
|
-433
|
-42.24%
|
✗
|
$213.4K |
|
Feb 5, 2026 |
Jeddi Iman
|
SVP & GM da Vinci Platforms & |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 5, 2026 |
WADORS PATRICIA L
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 29, 2026 |
Jan 30, 2026 |
Leonard Keith R
|
Director |
Neutral |
27.5
|
-369
|
-49.93%
|
✗
|
- |
| Jan 28, 2026 |
Jan 30, 2026 |
Brosius Mark
|
SVP & Chief Mfg and Supply Cha |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 28, 2026 |
Jan 30, 2026 |
LOEB GARY
|
EVP & Chief Legal and Complian |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 28, 2026 |
Jan 30, 2026 |
Rosa David J.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 29, 2026 |
Jan 30, 2026 |
Curet Myriam
|
EVP & Chief Medical Officer |
Sell |
11.3
|
-126
|
-26.30%
|
✓
|
$65.5K |
| Jan 28, 2026 |
Jan 30, 2026 |
GUTHART GARY S
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 28, 2026 |
Jan 30, 2026 |
Charlton Henry L
|
EVP & Chief Commercial and Mkt |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 28, 2026 |
Jan 30, 2026 |
Samath Jamie
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 27, 2026 |
Jan 28, 2026 |
Curet Myriam
|
EVP & Chief Medical Officer |
Sell |
11.3
|
-230
|
-39.45%
|
✓
|
$122.5K |
| Jan 27, 2026 |
Jan 28, 2026 |
GUTHART GARY S
|
Director |
Sell |
38.8
|
-27,300
|
-2.11%
|
✓
|
$14.5M |
| Dec 15, 2025 |
Dec 17, 2025 |
Brosius Mark
|
Officer |
Sell |
7.5
|
-464
|
-77.98%
|
✓
|
$254.5K |
| Dec 12, 2025 |
Dec 17, 2025 |
Brosius Mark
|
Officer |
Sell |
10.0
|
-312
|
-34.40%
|
✓
|
$170.8K |
| Dec 12, 2025 |
Dec 15, 2025 |
Brosius Mark
|
SVP & Chief Mfg and Supply Cha |
Sell |
5.0
|
-4,964
|
-91.81%
|
✓
|
$2.7M |
| Dec 10, 2025 |
Dec 10, 2025 |
Curet Myriam
|
EVP & Chief Medical Officer |
Sell |
15.0
|
-104
|
-22.76%
|
✓
|
$58.2K |
| Dec 1, 2025 |
Dec 2, 2025 |
Curet Myriam
|
EVP & Chief Medical Officer |
Sell |
10.0
|
-125
|
-26.15%
|
✓
|
$71.1K |
| Dec 1, 2025 |
Dec 2, 2025 |
GUTHART GARY S
|
Chair |
Sell |
37.5
|
-22,806
|
-1.77%
|
✓
|
$13M |
| Nov 12, 2025 |
Nov 13, 2025 |
Charlton Henry L
|
EVP & Chief Commercial and Mkt |
Sell |
3.8
|
-13,731
|
-28.65%
|
✓
|
$8M |
| Nov 12, 2025 |
Nov 13, 2025 |
BARRATT CRAIG H
|
Director |
Sell |
38.8
|
-750
|
-2.68%
|
✓
|
$435K |
| Nov 12, 2025 |
Nov 13, 2025 |
Leonard Keith R
|
Director |
Neutral |
27.5
|
-1,606
|
-68.49%
|
✗
|
- |
| Nov 10, 2025 |
Nov 12, 2025 |
Curet Myriam
|
EVP & Chief Medical Officer |
Sell |
15.0
|
-105
|
-22.93%
|
✓
|
$58.8K |
| Nov 10, 2025 |
Nov 12, 2025 |
Miller Brian Edward
|
EVP & Chief Digital Officer |
Sell |
10.0
|
-3,500
|
-23.31%
|
✓
|
$2M |
| Nov 5, 2025 |
Nov 6, 2025 |
Widman Fredrik
|
VP Corporate Controller |
Sell |
5.0
|
-2,067
|
-68.60%
|
✓
|
$1.1M |
| Nov 3, 2025 |
Nov 3, 2025 |
Rosa David J.
|
CEO |
Neutral |
27.5
|
-5,454
|
-2.33%
|
✗
|
- |
| Oct 28, 2025 |
Oct 29, 2025 |
Curet Myriam
|
EVP & Chief Medical Officer |
Sell |
5.0
|
-7,687
|
-84.48%
|
✓
|
$4.2M |
| Oct 24, 2025 |
Oct 27, 2025 |
GUTHART GARY S
|
Chair |
Sell |
33.8
|
-31,600
|
-2.44%
|
✓
|
$17.3M |
| Oct 24, 2025 |
Oct 27, 2025 |
BARRATT CRAIG H
|
Director |
Sell |
27.5
|
-2,193
|
-7.46%
|
✓
|
$1.2M |
| Oct 24, 2025 |
Oct 27, 2025 |
Rosa David J.
|
CEO |
Sell |
21.3
|
-24,500
|
-9.47%
|
✓
|
$13.4M |
| Oct 10, 2025 |
Oct 10, 2025 |
LOEB GARY
|
EVP & Chief Legal and Complian |
Sell |
40.0
|
-1,296
|
-26.68%
|
✗
|
$575.1K |
| Sep 3, 2025 |
Sep 4, 2025 |
Ladd Amy L
|
Director |
Sell |
7.5
|
-671
|
-47.59%
|
✓
|
$305.6K |
| Aug 29, 2025 |
Sep 2, 2025 |
GUTHART GARY S
|
Chair |
Sell |
33.8
|
-29,360
|
-2.27%
|
✓
|
$13.9M |
| Jul 28, 2025 |
Jul 29, 2025 |
GUTHART GARY S
|
Chair |
Sell |
38.8
|
-21,193
|
-1.66%
|
✓
|
$5.3M |
| Jul 25, 2025 |
Jul 25, 2025 |
Curet Myriam
|
EVP & Chief Medical Officer |
Sell |
5.0
|
-4,500
|
-92.73%
|
✓
|
$2.2M |
| Jul 10, 2025 |
Jul 11, 2025 |
Rosa David J.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 10, 2025 |
Jun 10, 2025 |
Rosa David J.
|
President |
Sell |
45.0
|
-674
|
-0.29%
|
✗
|
$354.6K |
| Jun 5, 2025 |
Jun 6, 2025 |
Brosius Mark
|
SVP & Chief Mfg and Supply Cha |
Sell |
10.0
|
-431
|
-32.21%
|
✓
|
$242.2K |
| Jun 4, 2025 |
Jun 4, 2025 |
Rosa David J.
|
President |
Neutral |
45.0
|
-851
|
-0.37%
|
✗
|
- |
| Jun 2, 2025 |
Jun 4, 2025 |
Brosius Mark
|
SVP & Chief Mfg and Supply Cha |
Sell |
7.5
|
-645
|
-32.53%
|
✓
|
$355.1K |
| May 15, 2025 |
May 16, 2025 |
Brosius Mark
|
SVP & Chief Mfg and Supply Cha |
Sell |
45.0
|
-42
|
-2.07%
|
✓
|
$23.6K |
| May 12, 2025 |
May 14, 2025 |
Brosius Mark
|
SVP & Chief Mfg and Supply Cha |
Sell |
41.3
|
-66
|
-3.16%
|
✓
|
$36.9K |
| May 2, 2025 |
May 5, 2025 |
Samath Jamie
|
Officer |
Sell |
22.5
|
-915
|
-11.33%
|
✓
|
$483.1K |
| May 1, 2025 |
May 1, 2025 |
Reed Monica P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 1, 2025 |
May 1, 2025 |
NACHTSHEIM JAMI K
|
Director |
Sell |
5.0
|
-2,400
|
-27.36%
|
✓
|
$1.2M |
| May 1, 2025 |
May 1, 2025 |
Leonard Keith R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 1, 2025 |
May 1, 2025 |
Kolli Sreelakshmi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 1, 2025 |
May 1, 2025 |
Johnson Amal M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 1, 2025 |
May 1, 2025 |
CHEW LEWIS
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 1, 2025 |
May 1, 2025 |
Beery Joseph C
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 1, 2025 |
May 1, 2025 |
BARRATT CRAIG H
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 30, 2025 |
May 1, 2025 |
Ladd Amy L
|
Director |
Sell |
5.0
|
-8,776
|
-55.45%
|
✓
|
$4.4M |
| Apr 25, 2025 |
Apr 29, 2025 |
DeSantis Robert
|
EVP & Chief Strategy & Corp Op |
Sell |
35.0
|
-990
|
-3.06%
|
✓
|
$508.5K |
| Apr 25, 2025 |
Apr 28, 2025 |
Curet Myriam
|
EVP & Chief Medical Officer |
Sell |
5.0
|
-4,000
|
-91.89%
|
✓
|
$2.1M |
| Apr 25, 2025 |
Apr 25, 2025 |
LOEB GARY
|
EVP & Chief Legal and Complian |
Sell |
7.5
|
-1,700
|
-43.09%
|
✓
|
$872.4K |
| Apr 25, 2025 |
Apr 25, 2025 |
NACHTSHEIM JAMI K
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 25, 2025 |
Apr 25, 2025 |
CHEW LEWIS
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 25, 2025 |
Apr 25, 2025 |
Johnson Amal M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 25, 2025 |
Apr 25, 2025 |
Reed Monica P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 25, 2025 |
Apr 25, 2025 |
BARRATT CRAIG H
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 25, 2025 |
Apr 25, 2025 |
Ladd Amy L
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 25, 2025 |
Apr 25, 2025 |
Kolli Sreelakshmi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 25, 2025 |
Apr 25, 2025 |
Leonard Keith R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 25, 2025 |
Apr 25, 2025 |
RUBASH MARK J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 25, 2025 |
Apr 25, 2025 |
Beery Joseph C
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 13, 2025 |
Mar 14, 2025 |
DeSantis Robert
|
EVP & Chief Strategy & Corp Op |
Sell |
18.8
|
-11,545
|
-10.74%
|
✓
|
$5.8M |
| Mar 11, 2025 |
Mar 12, 2025 |
Miller Brian Edward
|
EVP & Chief Digital Officer |
Sell |
8.8
|
-12,900
|
-23.29%
|
✓
|
$6.4M |
| Mar 7, 2025 |
Mar 7, 2025 |
Brosius Mark
|
SVP & Chief Mfg and Supply Cha |
Sell |
17.5
|
-489
|
-18.95%
|
✓
|
$260.7K |
| Mar 4, 2025 |
Mar 6, 2025 |
Brosius Mark
|
SVP & Chief Mfg and Supply Cha |
Sell |
7.5
|
-1,476
|
-36.39%
|
✓
|
$825K |
| Mar 5, 2025 |
Mar 6, 2025 |
Rosa David J.
|
President |
Sell |
31.3
|
-16,509
|
-3.48%
|
✓
|
$9.2M |
| Feb 27, 2025 |
Mar 3, 2025 |
Brosius Mark
|
SVP & Chief Mfg and Supply Cha |
Sell |
95.0
|
+1,283
|
6.31%
|
✓
|
$1.8M |